Skip to main content
. 2021 Mar 29;19(6):986–997. doi: 10.1016/j.gpb.2020.05.006

Table 6.

Comparison of iDTPnd with Dr. PRODIS and DTINet

Drug Dr. PRODIS
DTINet
Sensitivity for top 50 predicted targets Sensitivity for top 200 predicted targets Sensitivity for top 50 predicted targets Sensitivity for top 200 predicted targets
Sorafenib 18% 7.5% 14% 3.5%
Dasatinib 10% 21.5% 20% 5%
Imatinib 14% 27.5% 18% 4.5%
Sunitinib 14% 8% 16% 4%
Pazopanib --- --- --- ---
Average 14% 16% 17% 4.3%